Investing.com - Financial Markets Worldwide

ApicHope Pharmaceutical Co Ltd (300723)

Shenzhen
Currency in CNY
47.18
-1.04(-2.16%)
Closed·
300723 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
46.8648.46
52 wk Range
15.0181.48
Key Statistics
Edit
Bid/Ask
47.18 / 47.23
Prev. Close
48.22
Open
48.08
Day's Range
46.86-48.46
52 wk Range
15.01-81.48
Volume
5.93M
Average Volume (3m)
9.53M
1-Year Change
141.88%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300723 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
40.26
Downside
-14.67%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 11
Stock has taken a big hit over the last week
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

ApicHope Pharmaceutical Co Ltd Company Profile

ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao’er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxiangqingjie oral liquids, epinastine hydrochloride granules, clindamycin palmitate hydrochloride granules, clindamyxin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drops, montelukast sodium oral granules, oseltamivir phosphate capsules, and levocetirizine dihydrochloride oral drops. It also provides chronic disease drugs, including aciclovir for injection, hepatocyte growth-promoting factor for injection, pentoxifylline injection, kangshen and niaoqingshu granules, shenbo lotion, compound monoammonium glycyrrhizinate s and lansoprazole for injection, omeprazole sodium for injection, and other products. In addition, the company offers compound elsholtzia liquid, yinhuang oral liquid, and xiongdan chuanbei oral liquid products; levofloxacin hydrochloride for injection, ketorolac trometamol injection, phloroglucinol injection, ibuprofen tablets, vidarabine monophosphate for injection, lexofloxacin tablets, tranexamic acid injection, ropivacaine hydrochloride injection, mecobalamin injection, linezolid for oral suspension, clindamyxin hydrochloride for injection, caspofungin acetate for injection, and tongxuan lifei tablets. Further, it engages in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024. ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Guangzhou, China.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
1484
Market
China

Compare 300723 to Peers and Sector

Metrics to compare
300723
Peers
Sector
Relationship
P/E Ratio
−49.8x−6.9x−0.6x
PEG Ratio
2.000.070.00
Price/Book
12.2x3.0x2.6x
Price / LTM Sales
20.9x7.2x3.3x
Upside (Analyst Target)
−15.5%25.9%41.8%
Fair Value Upside
Unlock−16.4%6.2%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 40.26
(-14.67% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.95%
Dividend Yield
-
Industry Median 1.43%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Oct 29, 2025
EPS / Forecast
-0.14 / --
Revenue / Forecast
230.21M / --
EPS Revisions
a
a
Unlock
Last 90 days

300723 Income Statement

FAQ

What Stock Exchange Does ApicHope Pharmaceutical Trade On?

ApicHope Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for ApicHope Pharmaceutical?

The stock symbol for ApicHope Pharmaceutical is "300723."

What Is the ApicHope Pharmaceutical Market Cap?

As of today, ApicHope Pharmaceutical market cap is 21.19B.

What Is ApicHope Pharmaceutical's Earnings Per Share (TTM)?

The ApicHope Pharmaceutical EPS (TTM) is -0.95.

When Is the Next ApicHope Pharmaceutical Earnings Date?

ApicHope Pharmaceutical will release its next earnings report on 30 Oct 2025.

From a Technical Analysis Perspective, Is 300723 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ApicHope Pharmaceutical Stock Split?

ApicHope Pharmaceutical has split 2 times.

How Many Employees Does ApicHope Pharmaceutical Have?

ApicHope Pharmaceutical has 1484 employees.

What is the current trading status of ApicHope Pharmaceutical (300723)?

As of 03 Dec 2025, ApicHope Pharmaceutical (300723) is trading at a price of 47.18, with a previous close of 48.22. The stock has fluctuated within a day range of 46.86 to 48.46, while its 52-week range spans from 15.01 to 81.48.

What Is ApicHope Pharmaceutical (300723) Price Target According to Analysts?

The average 12-month price target for ApicHope Pharmaceutical is CNY40.26, with a high estimate of CNY44.64 and a low estimate of CNY35.88. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -14.67% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.